Prostate cancer is the second leading cause of cancer-related deaths in men, but one of the challenges in this disease has been the inability to differentiate between men who have aggressive tumors and those who have indolent tumors.…

Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center knows the wide range of emotions and fears that men with prostate cancer face.…

A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) CaseMedical Center along with colleagues at the Cleveland.…

Real-time elastography (RTE) significantly improves detection of prostate cancer (PCa) and extracapsular extension compared with grey-scale ultrasonography (GSU), according to researchers. …

The use of androgen-deprivation therapy (ADT) for two months before and two months during radiation therapy (RT) for early prostate cancer (PCa) is associated with significantly increased overall survival.…

Two researchers from Roswell Park Cancer Institute (RPCI) have opened a clinical trial that will assess the impact of dietary change to controlprostate cancer. The Men's Eating and Living (MEAL) study led by co-investigators James Mohler.…

Long-term use of acetaminophen is associated with a decreased risk of prostate cancer (PCa),according to a study. Previous epidemiologic studies have shown that use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDS).…